Sanifit Utilizes Calcium Phosphate Chemistry To Treat Rare Renal Disease
Executive Summary
Emerging company profile: Sanifit Laboratories, founded in 2007 as a spin-off from the University of the Balearic Islands, believes it has discovered a new approach to treating calcification disorders based on compounds that contain hexasodium phytate, which inhibits the formation and growth of calcium phosphate microcrystals in soft tissue.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.